Search

everythinglearnresearchcommunity

for

Search:↓

MFN2 mutations cause mitochondrial problems, leading to more upper body fat and lower leptin levels.

FOL-005 peptide may help treat excessive hair growth safely.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

High ODC and low K1 and K10 may indicate early skin tumors in mice.

STIM1 is essential for sweat secretion.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Eccrine gland activity may be linked to alopecia areata.

Keratinocyte growth factor significantly alters skin and tissue development.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Exosome therapy could be a promising new way to treat hair loss.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

Peps help Arabidopsis plants grow more root hairs by affecting specific genes and calcium signaling.

A20 protein is crucial for normal skin and hair development.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Certain genetic changes in the STX17 and KRT82 genes contribute to hair loss in alopecia areata.

The nano-carrier makes etoposide safer and more effective against lung cancer.

BMP signaling helps prevent skin tumors by blocking cancer-promoting pathways.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Modulating BMP activity changes the number, size, shape, and type of ectodermal organs.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.